These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4929048)

  • 41. [Endoxan cystitis].
    Kühböck J; Pecherstorfer M; Zilcher H
    Wien Klin Wochenschr; 1969 Sep; 81(39):679-80. PubMed ID: 5344300
    [No Abstract]   [Full Text] [Related]  

  • 42. [On quantitative changes in the leukocytes and thrombocytes after chemotherapy in patients with malignant tumors of the ovaries].
    Livshits MA
    Vopr Onkol; 1966; 12(8):42-6. PubMed ID: 4972210
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of patients with malignant ovarian tumors with high single doses of cyclophosphane].
    Loskutova GP
    Vopr Onkol; 1973; 19(9):98-9. PubMed ID: 4788400
    [No Abstract]   [Full Text] [Related]  

  • 44. [Kinetic patterns of changes in the number of peripheral blood leukocytes in lung cancer patients after treatment with cyclophosphane combined with cystaphos].
    Disvetova VV; Levitin EI; Trakhtenberg AKh; Batinov IN
    Izv Akad Nauk SSSR Biol; 1977; (3):351-6. PubMed ID: 886069
    [No Abstract]   [Full Text] [Related]  

  • 45. Unexpected toxicity in patients treated with iphosphamide.
    Van Dyk JJ; Falkson HC; Van der Merwe AM; Falkson G
    Cancer Res; 1972 May; 32(5):921-4. PubMed ID: 4552918
    [No Abstract]   [Full Text] [Related]  

  • 46. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant ovarian tumours in children and adolescents.
    Stasek V; Veselý K; Motlík K
    Neoplasma; 1971; 18(3):299-307. PubMed ID: 5093949
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical experience with the use of Bamfolin. 1].
    Yaoi H
    Yokohama Med Bull; 1968 Feb; 19(1):17-27. PubMed ID: 4300936
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chemotherapy in the terminal stages of tumors].
    Astrakhan VI; Garin AM; Vvedenskaia NA; Bychkov MB
    Vopr Onkol; 1968; 14(6):92-6. PubMed ID: 4881119
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclophosphamide therapy in patients with advancing breast cancer following adrenalectomy and 5-fluorouracil.
    Piro AJ; Wilson RE; Nevinny HB
    Cancer; 1971 Jun; 27(6):1342-5. PubMed ID: 5088210
    [No Abstract]   [Full Text] [Related]  

  • 53. Hemorrhagic cystitis in a child with Hodgkin lymphoma and ataxia-telangiectasia after cyclophosphamide.
    Kaymaz NE; Küpeli S; Yalçin B; Büyükpamukçu M
    Pediatr Blood Cancer; 2009 Sep; 53(3):516. PubMed ID: 19418546
    [No Abstract]   [Full Text] [Related]  

  • 54. Recent advances in chemotherapy of lymphoma.
    Lenhard RE; Owens AH
    Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
    [No Abstract]   [Full Text] [Related]  

  • 55. Shnider BI, Salvin LG, Schneiderman MA, Colsky J, Owens AH Jr,+OWENS AH JR, Krant MJ, Miller SP, Frei E 3d,+FREI E III, Hall TC, Spurr CL, McIntyre OR,+MACINTYRE OR, Hoogstraten B, Holland JF: The use of mechlorethamine, cyclophosphamide, and uracil mustard in neoplastic disease: a cooperative study.
    Gold GL
    J Clin Pharmacol J New Drugs; 1970; 10(2):110-20. PubMed ID: 4906539
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
    Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [1st clinical experiences with isophosphamide. Long-term results of 2 therapeutic approaches].
    Pigatto JC
    Prensa Med Argent; 1971 Oct; 58(32):1618-21. PubMed ID: 4943249
    [No Abstract]   [Full Text] [Related]  

  • 58. Further experience with isophosphamide.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1976 Jul; 60(7):955-7. PubMed ID: 1009528
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experience with Endoxan massive treatment].
    Kosaki G; Aoki Y; Kusakabe H; Taniguchi K; Takagi H
    Saishin Igaku; 1966 Nov; 21(11):2527-37. PubMed ID: 5979032
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antibacterial and antineoplastic antibiotics].
    Gol'dberg LE
    Sov Med; 1977 Oct; (10):115-23. PubMed ID: 201038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.